問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
鄭彩梅
下載
2022-01-05 - 2029-11-11
Condition/Disease
Test Drug
Participate Sites9Sites
Not yet recruiting1Sites
Recruiting8Sites
2018-02-01 - 2022-08-12
Participate Sites1Sites
Recruiting1Sites
2024-03-15 - 2031-12-31
Participate Sites10Sites
Recruiting9Sites
2024-09-30 - 2026-06-30
Participate Sites6Sites
Not yet recruiting5Sites
2022-08-01 - 2023-08-14
Participate Sites2Sites
Recruiting2Sites
2021-07-01 - 2023-02-01
Recruiting4Sites
Terminated2Sites
2020-11-30 - 2022-03-28
Membranous Nephropathy
MOR202
Participate Sites5Sites
Recruiting5Sites
2021-05-31 - 2023-03-14
Participate Sites4Sites
Not yet recruiting2Sites
2018-01-01 - 2022-01-31
Moderate to Severe Chronic Kidney Disease (stage 3B to 4)
ELIXCYTE
Participate Sites3Sites
Recruiting3Sites
Division of Nephrology
全部
